Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009683
Filing Date
2018-04-30
Accepted
2018-04-30 08:00:17
Documents
6
Period of Report
2018-06-21
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A alrn-def14a_20180621.htm DEF 14A 800926
2 GRAPHIC g2018042516420076818677.jpg GRAPHIC 2408
3 GRAPHIC g2018042516420920018680.jpg GRAPHIC 58248
4 GRAPHIC g2018042516420078618678.jpg GRAPHIC 4294
5 GRAPHIC g2018042516420057718676.jpg GRAPHIC 3993
6 GRAPHIC g2018042516420917418679.jpg GRAPHIC 55089
  Complete submission text file 0001564590-18-009683.txt   973557
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38130 | Film No.: 18786752
SIC: 2834 Pharmaceutical Preparations